Dendritic cell potentiation
AssigneeMayo Foundation for Medical Education and Research
InventorsLarry R. Pease, Moses Rodriguez, Daren Ure, Loc T. Nguyen, Suresh Radhakrishnan
Life of this patent
Estimating the term…
Abstract
A molecule capable of potentiating immune responses is described, as well as methods for using the molecule to enhance immune responses and enhance dendritic cell function. Also described are compositions containing the molecule and methods for using the compositions to treat or immunize individuals.
Claims3
A purified IgM antibody that binds to B7-DC polypeptides on a cell, wherein said binding results in cross-linking of a plurality of said B7-DC polypeptides, wherein said IgM antibody can potentiate an immune response upon administration to a mammal, wherein said IgM antibody is rHIgM12, and wherein the antibody is obtainable from the hybridoma deposited by Applicants as ATCC Designation number PTA-8932.
A purified IgM antibody that binds to B7-DC polypeptides on a cell, wherein said binding results in cross-linking of a plurality of said B7-DC polypeptides, wherein said IgM antibody can potentiate an immune response upon administration to a mammal, and wherein said IgM antibody has a heavy chain with the N-terminal sequence set forth in SEQ ID NO:3.
A purified IgM antibody that binds to B7-DC polypeptides on a cell, wherein said binding results in cross-linking of a plurality of said B7-DC polypeptides, wherein said IgM antibody can potentiate an immune response upon administration to a mammal, and wherein said IgM antibody has a light chain with the N-terminal terminal sequence set forth in SEQ ID NO:4.
Dependencies are inferred from the claim text.